20 August 2022 in Russian Journal of Cardiology
Hypertension (HTN) remains one of the most important risk factors for cardiovascular events. Modification of additional risk factors, along with a blood pressure decrease, significantly affects the risk of cardiovascular events. Hyperuricemia is one of the new factors that has a high prevalence in the population and affects the risk for cardiovascular events in hypertensive patients. In the treatment with fixed-dose combinations in patients with hypertension and hyperuricemia, metabolic neutrality is of particular importance. When prescribing diuretics, the practitioner faces additional difficulties. These drugs are highly synergistic when added to other major antihypertensives’ classes, but, in some cases, may worsen the metabolic profile. The use of the thiazide-like diuretic indapamide largely avoids a negative effect on the metabolic profile, making it the preferred choice for patients with hyperuricemia.
31 July 2021 in Kardiologiia
Aim Improvement of quality of life is one of the most important goals for the treatment of patients with chronic heart failure (CHF). This study searched for ways to increase the efficiency of CHF treatment based on parameters of quality of life in CHF patients during and after the treatment with exogenous phosphocreatine (EP). Material and methods The effect of a single course of EP treatment on quality of life of patients with functional class (FC) II-IV CHF with reduced or mid-range left ventricular ejection fraction was studied as a part of the all-Russia prospective observational study BYHEART. The presence of FC II-IV CHF and a left ventricular ejection fraction <50 % were confirmed by results of 6-min walk test (6MWT) and findings of echocardiography after stabilization of the background therapy. Results An interim data analysis showed that the course of EP treatment was associated with a significant improvement of quality-of-life indexes as determined by the Minnesota Living with Heart Failure Questionnaire (LHFQ) total score. These indexes significantly increased and remained at a satisfactory level for 6 mos. following completion of the treatment course. Also, the treatment significantly beneficially influenced the clinical condition of patients (heart failure severity scale), results of 6MWT, and the increase in left ventricular ejection fraction. Conclusion The conclusions based on results of the interim analysis should be confirmed by results of the completed study. Complete results are planned to be published in 2022.
23 January 2025 in Medical alphabet
The article presents an intriguing clinical case of myocarditis in a 36-year-old patient following severe sunburn. The disease developed with a pronounced pain syndrome, a significant increase in high-sensitivity troponin levels, and notable changes in the electrocardiogram (ECG). These factors complicated the differential diagnosis between acute coronary syndrome (myocardial infarction without coronary obstruction) and myocarditis. The rapid regression of clinical symptoms, normalization of myocardial injury biomarkers, atypical ECG dynamics for myocardial infarction, and the absence of coronary artery changes during angiography—alongside magnetic resonance imaging data revealing no areas of ischemic changes but showing inflammatory changes and myocardial edema—contributed to a diagnosis of myocarditis. Dynamic observation two months post-diagnosis indicated no deviations from standard indicators. The article also reviews literature on the mechanisms of myocardial damage associated with sunburn, which differ significantly from those seen in thermal and chemical burns. The authors suggest that severe sunburn is the most likely etiological factor for the observed damage, highlighting the potential for injury not only to the skin but also to internal organs.